Taking IBD Treatment in STRIDE: How Objective Disease Assessment Is Essential for the Successful Implementation of Treat-to-Target Strategies
Crossref DOI link: https://doi.org/10.1007/s10620-023-08221-8
Published Online: 2024-01-13
Published Print: 2024-03
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Stallmach, Andreas http://orcid.org/0000-0002-6101-5244
Grunert, Philip C.
Funding for this research was provided by:
Universitätsklinikum Jena
Text and Data Mining valid from 2024-01-13
Version of Record valid from 2024-01-13
Article History
Received: 15 November 2023
Accepted: 27 November 2023
First Online: 13 January 2024